Rep. Perry Introduces TREAT PTSD TRICARE Act to Expand Nerve Block Therapy for Service Members
This bill is in the early stages of the legislative process and is currently sitting with the House Committee on Armed Services. The committee must review the bill before it can move forward, but no action has occurred since May 11, 2026. Most bills do not receive a committee vote, so this proposal is not actively moving at this time.
While there is often strong support for military health, most bills introduced in the House never make it past the committee stage without a large number of cosponsors.
Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
Reserve component members who have performed active service and are enrolled in TRICARE would also qualify for this treatment. While the bill specifically covers Armed Forces members (including reserves) rather than all veterans, the required update to the VA/DOD Clinical Practice Guideline could indirectly influence VA treatment options over time by formally recognizing stellate ganglion block as a PTSD therapy.
“Not later than 180 days after the date of the enactment of this Act, the Secretary of Defense shall update the guideline titled the ``VA/DOD Clinical Practice Guideline (CPG) for the Management of PTSD''”
Referred to the House Committee on Armed Services.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
No votes, news coverage, or related bills recorded for this bill yet.
Document Type
Congressional Bill
Official Title
TREAT PTSD TRICARE Act
Analysis generated by AI. Always verify with official sources.